» Articles » PMID: 22850323

Evaluation of the Pharmacological Function of Ulinastatin in Experimental Animals

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2012 Aug 2
PMID 22850323
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Organ protection is a routine therapy in severe injuries. Our aim was to evaluate the beneficial effects of ulinastatin in experimental rats. Rats were randomly divided into a sham control, a model control and an ulinastatin-treated group. Malondialdehyde (MDA) and superoxide dismutase (SOD) levels were determined. Serum amylase, serum aspartate aminotransaminase (AST), lactate dehydrogenase (LDH) and creatine kinase isoenzyme (CKMD) activities, interleukin-8 (IL-8), tumor necrosis factor-α (TNF-α), nitric oxide (NO) and cardiac troponin I (nTnl) levels were examined. Results showed that ulinastatin decreased MDA levels and ameliorated the down-regulation of SOD activity. In addition, ulinastatin pretreatment may decrease serum AST, LDH and CKMD activities, IL-8, TNF-α, and nTnl levels, and enhance NO level. Our results demonstrated that oxidative injury occurred after IR and that ulinastatin exhibits significant protective effects against these effects.

Citing Articles

Ulinastatin attenuates renal fibrosis by regulating AMPK/HIF-1α signaling pathway-mediated glycolysis.

Wei X, Long M, Fan Z, Hou Y, Yang L, Du Y Sci Rep. 2024; 14(1):28032.

PMID: 39543285 PMC: 11564816. DOI: 10.1038/s41598-024-78092-0.


Ulinastatin protects against sepsis‑induced myocardial injury by inhibiting NLRP3 inflammasome activation.

Qiu J, Xiao X, Gao X, Zhang Y Mol Med Rep. 2021; 24(4).

PMID: 34414461 PMC: 8404092. DOI: 10.3892/mmr.2021.12369.


Ulinastatin: A Potential Alternative to Glucocorticoid in the Treatment of Severe Decompression Sickness.

Meng W, Qing L, Li C, Zhang K, Yi H, Zhao X Front Physiol. 2020; 11:273.

PMID: 32273851 PMC: 7113395. DOI: 10.3389/fphys.2020.00273.


Cryptdin-2 predicts intestinal injury during heatstroke in mice.

Ji J, Gu Z, Li H, Su L, Liu Z Int J Mol Med. 2017; 41(1):137-146.

PMID: 29115396 PMC: 5746321. DOI: 10.3892/ijmm.2017.3229.


Ulinastatin inhibits oxidant-induced endothelial hyperpermeability and apoptotic signaling.

Li G, Li T, Cai S, Zhang Z, Zeng Z, Wang X Int J Clin Exp Pathol. 2015; 7(11):7342-50.

PMID: 25550770 PMC: 4270631.


References
1.
Inoue K, Takano H, Shimada A, Yanagisawa R, Sakurai M, Yoshino S . Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Mol Pharmacol. 2004; 67(3):673-80. DOI: 10.1124/mol.104.005967. View

2.
Winterbourn C, Hawkins R, Brian M, Carrell R . The estimation of red cell superoxide dismutase activity. J Lab Clin Med. 1975; 85(2):337-41. View

3.
White M, Hambly B, Jeremy R, Cordwell S . Ischemia-specific phosphorylation and myofilament translocation of heat shock protein 27 precedes alpha B-crystallin and occurs independently of reactive oxygen species in rabbit myocardium. J Mol Cell Cardiol. 2006; 40(6):761-74. DOI: 10.1016/j.yjmcc.2006.02.007. View

4.
Kaya Z, Katus H, Rose N . Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure. Clin Immunol. 2009; 134(1):80-8. PMC: 2819185. DOI: 10.1016/j.clim.2009.04.008. View

5.
Garcia-Dorado D, Agullo L, Sartorio C, Ruiz-Meana M . Myocardial protection against reperfusion injury: the cGMP pathway. Thromb Haemost. 2009; 101(4):635-42. View